Objectives-The purpose of this study was to evaluate vascular function, including arterial resistance and endothelial function, by high-resolution sonography in an N xnitro-L-arginine methyl ester hydrochloride (L-NAME)-induced mouse model of preeclampsia-like symptoms.
P reeclampsia, which is associated with new-onset hypertension after 20 weeks' gestation, proteinuria, intrauterine growth restriction, 1 and vascular dysfunction, [2] [3] [4] is a multisystemic disorder whose underlying cause is unknown. Preeclampsia is a major cause of maternal-fetal morbidity and mortality worldwide. In addition, over the long term, preeclampsia may increase the risk of maternal cardiovascular disorders. 5 The development of reproducible viable animal models over the past decade has contributed substantially to a better understanding of the pathophysiologic mechanism of preeclampsia, as well as the development of new treatments to reduce its incidence and severity preeclampsia. 6 Nitric oxide, a potent vasodilator and angiogenic factor, 7 is synthesized from the amino acid Larginine by nitric oxide synthase. Chronic inhibition of nitric oxide synthase using N x -nitro-L-arginine methyl ester hydrochloride (L-NAME) in pregnant mice led to the development of a model characterized by hypertension, proteinuria, and intrauterine growth restriction, similar to those of preeclampsia. [8] [9] [10] [11] [12] [13] It is a common preeclampsia-like model. 8, 14 However, there are no studies on models of vascular function. Doppler sonography, a rapid noninvasive technique that provides valuable information about the maternal-fetal hemodynamic situation, has been routinely used to monitor high-risk pregnancies 15 in many species, including humans. [16] [17] [18] [19] Consistent evaluations of fetal and maternal vascular Doppler velocities in mice is possible using highfrequency sonography. 17 In this study, we attempted to assess the resistive index and pulsatility index (RI and PI, indicators of arterial resistance) of the uteroplacental, umbilical, femoral, and common carotid arteries and the flow-mediated dilatation (index of endothelial function) of the femoral artery in the model using the highresolution technology of the Vevo 2100 ultrasound system (Visual Sonics, Toronto, Ontario, Canada) for the first time.
Materials and Methods

Animals
Adult male and female C57BL/6 mice weighing 18 to 20 g were obtained from the Laboratory Animal Center of the Academy of Military Medical Sciences (Beijing, China) and received humane care in compliance with the Guide for the Care and Use of Laboratory Animals (US National Institutes of Health, Bethesda, MD; publication 85-23, revised 1996). They were provided free access to standard mouse chow and tap water and were maintained under controlled conditions of temperature (238C), humidity (40%-60%), and lighting (12/ 12 light/dark cycle) 1 week before the experiments. Vaginal smears were obtained daily from female mice until the vaginal cytologic findings were indicative of estrus, which was estimated as the day of the luteinizing hormone peak. The female mice were mated with male mice (2:1) and assessed for vaginal plugs the following morning, which was designated gestational day 0. On gestational day 0, the female mice were assigned to 2 groups (n 5 10 each). On gestational day 7, L-NAME (60 mg/kg/d; Sigma Aldrich, St Louis, MO) or normal saline (similar dose) was administered subcutaneously.
Blood Pressure Measurement
Systolic blood pressures (SBPs) were measured before grouping and on gestational days 6, 8, 10, 12, 14, 16 , and 18 via the indirect method of tail cuff occlusion in conscious animals with a CODA monitor system (Kent Scientific, Torrington, CT).
Twenty-four-Hour Urinary Protein Monitoring
Metabolic cages were used to collect 24-hour urine on gestational days 6 and 18. Twenty-four-hour urine outputs were recorded, and the concentration of protein was detected with a bicinchoninic acid protein assay kit (Thermo Scientific, South Logan, UT). Subsequently, the 24-hour urine protein concentration was determined.
Sonographic Evaluations
Pregnant mice (gestational day 18) were anesthetized with isoflurane (2% induction and 1.5% maintenance), and the core body temperature was maintained at 378C 6 18C on a heated examination table that was also equipped with electrocardiographic electrodes. All hair on the neck, abdomen, and lower right limb was removed via shaving gel, and a vascular closure device (5-mm diameter; DOCXS, Ukiah, CA) was used to compress the distal hind limb to trigger ischemia ( Figure  1, A and B) . The femoral, common carotid, uteroplacental, and umbilical arteries were visualized with MS550D and MS400 transducers on a Visual Sonics Vevo 2100 ultrasound system. Two random uteroplacental and umbilical arteries (1 random in each uterine horn) per pregnant dam were examined. The uteroplacental arteries were located on the maternal side of the placenta (see Figure 4D ). Two-dimensional sonography was used to identify the diameter of the femoral artery, and color and pulsed wave Doppler imaging was subsequently used to obtain the waveforms. To minimize variability, 3 uniform consecutive waveforms of each artery were recorded to measure the peak systolic velocity, end-diastolic velocity, and mean velocity.
After identification of the femoral artery by its characteristic flow pattern, the position of the probe was optimized to obtain clear vessel wall-lumen interfaces. When the clearest image of the vessel walls was obtained ( Figure 1 , C and D), the probe was fixed in a stand and not changed throughout the investigations. The vessel diameter (during diastoles) and blood velocity were measured at baseline and at 0, 60, 120, 180, 240, and 300 seconds after 5 minutes of compression. The above measurements (still images and video clips/ cine loops) were stored digitally for offline analysis for the RI [(peak systolic velocity -end-diastolic velocity)/peak systolic velocity], PI [(peak systolic velocity -end-diastolic velocity)/mean velocity], flowmediated dilatation [(diameter after cuff deflation ] -diameterbaseline )/diameter baseline 3 100%], 20 and wall shear stress 5 8 3 l 3 velocity/ diastolic /diameter diastolic . 20 Tissue Preparation and Placental Histopathologic Examination Termination of pregnancy was performed on gestational day 18 via cesarean delivery under isoflurane. The placentas and delivered pups from the horns of the uterus were examined for weight, length, and number, and the resorptions were inspected. Placentas were quickly removed, the blood being washed out with an ice-cold 0.9% saline solution, fixed in 40-g/L paraformaldehyde, and embedded in paraffin. Seven-micrometer paraffin sections were stained with hematoxylin-eosin and observed under a light microscope (Nikon, Tokyo, Japan).
Statistical Analysis
Data are presented as means 6 standard errors. The blood pressure and urine protein of pregnant mice and parameters of fetal, placental, and sonographic measures between groups were compared by independentsamples t tests. The association between sonographic measures was tested with Pearson or Spearman correlation coefficients. We estimated 95% confidence intervals of proteinuria in the control group and defined the upper limit of 95% confidence intervals 1 2 SDs (1.05 mg/24 h) as a successfully induced preeclampsialike model in the L-NAME group. Logistic regression was performed to assess the contribution of sonographic measures toward discrimination between the control and L-NAME groups. The diagnostic ability of flowmediated dilatation to separate the control from the preeclampsia model was assessed by a receiver operating characteristic analysis, and an optimal cutoff was determined as one with the maximum sum of specificity and sensitivity. P < .05 was considered significant.
Results
Blood Pressure
The mean SBPs on gestational day 6 were 113 6 0.455 mm Hg in the control group and 114 6 0.661 mm Hg in the group of pregnant mice awaiting L-NAME treatment (P > .05). Once L-NAME was administered, the mean SBP of the pregnant mice in the L-NAME group was increased on gestational day 8 and maintained until gestational day 18. The mean SBP was significantly increased compared with the control group (P < .001; Figure 2A ).
Twenty-four-Hour Urinary Protein
As shown in Figure 2B , the 24-hour urinary protein concentration was not statistically different between the groups on gestational day 6 (0.556 6 0.0363 versus 0.536 6 0.0359 mg/24 h; P > .05). However, compared with the control group, it was significantly increased in the L-NAME group on gestational day 18 (0.653 6 0.0475 versus 1.42 6 0.150 mg/24 h; P < .001).
Morphometric Analysis
The number of resorptions in the L-NAME group was increased compared with the other, and there were no malformations in the fetuses in both groups (12 of 66 [18.2%] versus 2 of 69 [2.9%]). The mean weight of the6fetuses (0.968 6 0.0166 versus 0.813 6 0.0175 g), crown-rump length of the fetuses (1.98 6 0.0142 versus 1.85 6 0.0223 cm), and weight of the placentas (0.0839 6 0.00160 versus 0.0741 6 0.00210 g) in the L-NAME group were significantly decreased compared with the control group (P < .001; Figure 3 , B, C, and E). There were no significant differences in the diameters of the placentas (0.702 6 0.00540 versus 0.693 6 0.00890 cm; P > .05; Figure 3F ). Morphologic changes in the placenta were observed under a light microscope. Villi formed a complicated labyrinth-like structure with maternal blood cells occupying the spaces of the mesh, which was involved in the exchange of material between the maternal and fetal blood. On gestational day 18, normal histologic structures were observed in the control group. However, increased syncytial knots were noted in the L-NAME group, which decreased blood flow of the placenta (Figure 3, A and D ).
Resistive and Pulsatility Indices
As expected, in this study, the RIs and PIs of the uteroplacental (0.501 6 0.0185 versus 0.709 6 0.0475; P < .001; and 0.804 6 0.0837 versus 1.39 6 0.163; P < .01) and umbilical (0.823 6 0.0192 versus 0.938 6 0.00340; P < .001; and 1.67 6 0.0649 versus 2.29 6 0.100; P < .001) arteries were increased in the L-NAME group. No significant differences in the indices were noted for the femoral and common carotid arteries (Figure 4) . Figure 3 . Changes in fetuses and placentas between control and L-NAME groups on gestational day 18. A, Normal labyrinth in the control group (hematoxylin-eosin, original magnification 3 400). D, Increased syncytial knots (arrow) in the L-NAME group (hematoxylin-eosin, original magnification 3 400). B, C, E, and F, Box-and-whisker plots showing the range of fetal weight, crown-rump length, placental weight, and placental diameter in the control and L-NAME groups. Lower and upper whiskers are 5% and 95% (median 5 1.00, 0790; 2.00, 1.86; 0.070, 0.080; and 0.680, 0.700); n 5 79 in control, n 5 61 in L-NAME (6-8 fetuses per pregnant dam). Circles indicate outliers of the 5% to 95%. ***P <.001. 
Flow-Mediated Dilatation and Wall Shear Stress
After 5 minutes of ischemia, deflation of the cuff led to an immediate increase in flow velocity, which was associated with a subsequent increase in wall shear stress of the upstream conduit artery. We observed the maximum flow velocity at the onset of reperfusion, and no difference was observed between the groups (72.0 6 1.10 versus 70.3 6 2.31 mm/s; P > .05). This change, in turn, led to parallel increases in wall shear stress, which showed significant differences at 60, 120, and 180 seconds between the L-NAME and control groups, especially at 120 seconds (153 6 2.06 versus 167 6 2.56 dyn/cm 2 ; P 5 .001). This effect was followed by significant dilatation, with a maximum at 120 seconds in the control group. Our experiment revealed a similar response pattern of flow-mediated dilatation in the L-NAME group compared with the control group, yet with a lower effect size (P < .001; Figure 5 ).
Correlations and Estimated Area Under the Receiver Operating Characteristic Curve
The correlation coefficients between sonographic measures and fetal outcomes are shown in Table 1 . All values showed significant differences except placenta; weight and PI umbilical , placental weight and RI umbilical , RI uteroplacental and PI umbilical , RI uteroplacental and RI umbilical , and PI uteroplacental and PI umbilical (P > .05). The result of a multivariate analysis using a logistic regression model was that flow-mediated dilatation at 120 seconds was an independent diagnostic criterion for the L-NAME-treated preeclampsia model (odds ratio, 0.670; 95% confidence interval, 5 0.482- Figure 5 . Hemodynamic changes in the femoral artery due to 5 minutes of hind limb ischemia between groups. A, Flow velocity during systole. B, Wall shear stress (WSS). C, Flow-mediated dilatation (FMD); n 5 10. *P <.05; **P <.01; ***P <.001 versus baseline before ischemia. 0.933; P < .05). The greatest area under the receiver operating characteristic value for flow-mediated dilatation at 120 seconds was 0.934 (P < .01) with an optimal cutoff point of 11.1%, yielding sensitivity of 100% and specificity of 84.6% ( Figure 6 ).
Discussion
At present, preeclampsia-like models are monitored on the basis of hypertension, proteinuria, and poor fetal outcomes, which agree with our study. We noted increased atrial resistance and endothelial dysfunction in the L-NAME-induced preeclampsia-like mouse model on high-resolution sonography. The PIs and RIs of the uteroplacental and umbilical arteries were associated with the intrauterine condition of the fetus, and the flowmediated dilatation of the femoral artery was an independent diagnostic criterion for the L-NAME-induced preeclampsia model. In 2 separate but simultaneous publications in 1974, Gosling and King 21 and Pourcelot 22 introduced the concepts of the PI and RI to identify pathologic resistance within a peripheral blood vessel using Doppler sonography These parameters reflect fundamental regulation of blood flow, matching the demand and supply of the tissue. During normal pregnancies, progressive increases in flow velocity in the uteroplacental and umbilical arteries are essential for the expansion of the fetoplacental vasculature in the labyrinth as an adaptation to the growing fetus. 17, 23 Increasing RIs and PIs of the umbilical and uteroplacental arteries mean greater resistance in the placental microcirculation in pregnancies complicated by hypertension and intrauterine growth restriction. [23] [24] [25] [26] [27] Both the PI and RI of the uterine arteries in patients with preeclampsia were significantly higher than those in a control group. 28 In our study, the PIs and RIs of the umbilical and uteroplacental arteries increased significantly in the L-NAME group to inhibit the growth of the fetus. They are noninvasive indicators for evaluating the condition of the fetus.
Flow-mediated dilatation, measured as changes in the conduit artery diameter after temporary ischemia, is one of the noninvasive parameters for measuring endothelial cell dysfunction. 29 Healthy arteries dilate via the release of nitric oxide or other endothelium-derived vasoactive substances. Patients with preeclampsia had reduced flow-mediated dilatation before the development of preeclampsia, at the time of preeclampsia, and for 3 years postpartum, even excluding women with chronic hypertension, smokers, or both. 30 We present the fundamental physiologic mechanism of flowmediated dilatation in the hind limb of mice, which is analogous to human flow-mediated dilatation measurements. We found that transient hind limb ischemia (5 minutes) led to reactive hyperemia with flow velocity and wall shear stress increases and was followed by femoral artery dilatation. However, the latter was partly abolished by administration of L-NAME for 10 days. Endothelial dysfunction potentially plays a critical role in preeclampsia. 30 Flow-mediated dilatation at 120 seconds was an independent diagnostic criterion for the L-NAME-treated preeclampsia model.
Our study was limited by its small sample size and lack of data about sonographic measures during early and middle pregnancy. Pulsed ultrasound can produce damage to biological tissues in vivo. 31 A previous study demonstrated that greater than 4 MHz for 30 minutes can result in worse effects on embryos. 32 In conclusion, we used high-frequency sonography for the first time to evaluate vascular dysfunction in an L-NAME-induced mouse model of preeclampsia-like symptoms. The study demonstrated that the PI and RI of the fetomaternal vasculature are noninvasive indicators for identifying fetuses in "high-risk" pregnancies and Figure 6 . Receiver operating characteristic analysis for the diagnosis of the L-NAME-treated preeclampsia model. The receiver operating characteristic curve shows the optimal cutoff point for flow-mediated dilatation at 120 seconds of 11.1% as the criterion for evaluation of vascular dysfunction in a mouse model of preeclampsia induced by L-NAME, yielding 100% sensitivity and 84.6% specificity. AUC indicates area under the curve.
that flow-mediated dilatation is a reliable predictor of model reproducibility. Therefore, our approach may provide a novel method for objective evaluation of the preeclampsia animal model, which is a useful platform for testing therapeutic efficacy in future translational research.
